[{"NetIncomeLoss_1_Q3_USD":-17705000.0,"MarketableSecuritiesCurrent_0_Q3_USD":399110000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":59761000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":11326000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":38914789.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":42185824.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":412000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":400411000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-39055000.0,"Depreciation_1_Q3_USD":200000.0,"Depreciation_3_Q3_USD":647000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":1820320.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":40000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":872000.0,"AssetsCurrent_0_Q3_USD":718163000.0,"OperatingLeaseExpense_3_Q3_USD":1100000.0,"OperatingLeaseExpense_1_Q3_USD":400000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":6690720.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":508000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":1718000.0,"IncomeTaxesPaidNet_3_Q3_USD":1000.0,"CommonStockSharesIssued_0_Q3_shares":42213364.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":399110000.0,"AmortizationOfLeasedAsset_3_Q3_USD":1139000.0,"Assets_0_Q3_USD":724633000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"OperatingLeaseLiability_0_Q3_USD":4144000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-606000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":141000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":410000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":79136000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":32213000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":27.32,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":4668000.0,"EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares_0_Q3_shares":263879.0,"PaymentsOfFinancingCosts_3_Q3_USD":114000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0_Q3_shares":2793909.0,"ProceedsFromStockPlans_3_Q3_USD":1068000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3_Q3_pure":0.793,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q3_pure":0.804,"CommonStockValue_0_Q3_USD":5000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-606000.0,"RevenueRemainingPerformanceObligation_0_Q3_USD":25700000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":352565000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":312986000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":710461000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-109775000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-18311000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":2686000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3_Q3_pure":0.0127,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q3_pure":0.004,"OtherAssetsNoncurrent_0_Q3_USD":268000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":312278000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":2789000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":933971000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_3_Q3_USD":-929000.0,"OtherOperatingIncome_1_Q3_USD":834000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q3_USD":13.22,"OperatingLeaseRightOfUseAsset_0_Q3_USD":3651000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.42,"OtherLiabilitiesCurrent_0_Q3_USD":25000.0,"StockholdersEquity_0_Q3_USD":701588000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":874000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":398698000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-175000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":6669220.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-232800000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":264090000.0,"CommonStockSharesOutstanding_0_Q3_shares":42213364.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":351167000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":1217000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":452000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":8564000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-49420000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":1668000.0,"LiabilitiesCurrent_0_Q3_USD":20256000.0,"AccountsPayableCurrent_0_Q3_USD":4552000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":6775000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q3_USD":207141000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":54653.0,"OperatingLeasePayments_3_Q3_USD":1200000.0,"OperatingLeasePayments_1_Q3_USD":400000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":2551000.0,"NetIncomeLoss_3_Q3_USD":-109916000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-2.82,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":3423000.0,"OperatingExpenses_1_Q3_USD":43539000.0,"OperatingExpenses_3_Q3_USD":138897000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":9512473.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":18.26,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":41.96,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q3_USD":44.97,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":524000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":978000.0,"CommonStockSharesAuthorized_0_Q3_shares":200000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":25000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":25000000.0,"OperatingIncomeLoss_3_Q3_USD":-113897000.0,"ShareBasedCompensation_3_Q3_USD":54333000.0,"OperatingIncomeLoss_1_Q3_USD":-18539000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":61.8,"PreferredStockValue_0_Q3_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":10.31,"LiabilitiesAndStockholdersEquity_0_Q3_USD":724633000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":5807000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":54333000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":8564000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":98800000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":350716.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":3768000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1355000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q3_shares":2579374.0,"OtherOperatingIncome_3_Q3_USD":3981000.0,"Ticker":"TPTX","CIK":"1595893","name":"TURNING POINT THERAPEUTICS, INC.","OfficialName":"Turning Point Therapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1579986704.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201112"}]